Instrument Inactif

Autres langues OSI Pharmaceuticals, Inc.

Actions

US6710401034

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

17/05/10

OSI PHARM : a reçu une offre de rachat du japonais Astellas

Autres langues

09/06/10	OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals
08/06/10	OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI
04/06/10	OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes
03/06/10	OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
17/05/10	OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010
17/05/10	OSI PHARM : Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
23/04/10	OSI PHARM : Expiration Date of OSI Offer Extended to May 17, 2010
31/03/10	OSI PHARM : Expiration Date of OSI Offer Extended to April 23, 2010
29/03/10	OSI PHARM : Astellas Signs Confidentiality Agreement With OSI
19/03/10	OSI PHARM : Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
16/03/10	OSI PHARM : Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting
15/03/10	OSI PHARM : Astellas Responds to OSI Pharmaceuticals' Rejection
02/03/10	OSI PHARM : Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
01/03/10	OSI PHARM : Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals to Present at the UBS Global Life Sciences Conference on Wednesday, September 26, 2007
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Summarizes Data Presented on Tarceva(R) (erlotinib) at the 12th World Congress on Lung Cancer Meeting
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Announces Positive Results from a Metformin Drug Interaction Study with Its DP-IV Inhibitor, PSN9301
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Announces Second Quarter 2007 Financial Results
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals to Announce Second Quarter Financial Results on July 30, 2007
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Announces Conversion Period for Convertible Notes
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals Announces the Election of Kenneth B. Lee, Jr. to Its Board
30/11/-1	Osi Pharmaceuticals : OSI Pharmaceuticals to Present at the Goldman Sachs 28th Annual Global Healthcare Conference on Thursday, June 14, 2007